Fig. 6

The correlation between ICI Score and IC₅₀ of different chemotherapeutic drugs. A Estimated IC₅₀ of Camptothecin between the high and low ICI Score groups; B Estimated IC₅₀ of Doxorubicin between the high and low ICI Score groups; C Estimated IC₅₀ of Mitomycin between the high and low ICI Score groups; D Estimated IC₅₀ of Docetaxel between the high and low ICI Score groups; E Estimated IC₅₀ of Cisplatin between the high and low ICI Score groups; F Estimated IC₅₀ of Vinblastine between the high and low ICI Score groups; G Estimated IC₅₀ of Sorafenib between the high and low ICI Score groups; H Estimated IC₅₀ of Paclitaxel between the high and low ICI Score groups